Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19.

导出原文传递

翻译打印收藏纠错

作者： Iago Dillion Lima,Cavalcanti ^[1] ; Sandrelli Meridiana,de Fátima Ramos Dos Santos Medeiros ^[1] ; Daniel Charles,Dos Santos Macêdo ^[1] ; Isabella Macário,Ferro Cavalcanti ^[1] ; Mariane Cajubá,de Britto Lira Nogueira ^[1]

作者单位： Laboratory of Immunopathology Keizo-Asami (LIKA), Federal University of Pernambuco (UFPE), Recife, Brazil. ^[1]

关键词 COVID-19 SARS-CoV-2 epidemiology.hydroxychloroquine nanotechnology respiratory syndrome

主题词抗病毒药(Antiviral Agents);药物载体(Drug Carriers);人类(Humans);羟氯喹(Hydroxychloroquine);纳米粒子(Nanoparticles);呼吸系统(Respiratory System)

DOI 10.2174/1567201817666200827110445

PMID 32860358

发布时间 2022-12-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Current drug delivery

2021年18卷5期

583-595页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19.

Current drug delivery

相似文献

Current drug delivery

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Nanocarriers in the Delivery of Hydroxychloroquine to the Respiratory System: An Alternative to COVID-19.

Current drug delivery

相似文献

Current drug delivery

相关期刊

检索历史清除